The STD diagnostics market is expected to expand from $9.8 billion in 2023 to $18.4 billion by 2033,
The STD diagnostics market encompasses the industry dedicated to the development, production, and distribution of diagnostic tests and technologies for sexually transmitted diseases. This market includes a range of products such as rapid tests, point-of-care diagnostics, laboratory-based testing solutions, and advanced molecular diagnostics. It serves to facilitate early detection, accurate diagnosis, and effective management of STDs, thereby playing a critical role in public health initiatives and disease control efforts globally.